Katherine Kedzierska Selected Research

Lipopeptides

5/2012	Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
8/2007	The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
3/2006	Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine Kedzierska Research Topics

Disease

84	Infections 05/2024 - 03/2002
69	Human Influenza (Influenza) 01/2024 - 06/2004
28	COVID-19 01/2024 - 01/2020
12	Virus Diseases (Viral Diseases) 06/2022 - 08/2007
7	Inflammation (Inflammations) 05/2024 - 01/2015
6	Neoplasms (Cancer) 02/2021 - 05/2011
4	Malaria 01/2021 - 01/2020
3	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 03/2017
3	Communicable Diseases (Infectious Diseases) 01/2021 - 12/2014
2	Multiple Sclerosis 03/2024 - 01/2022
2	Pneumonia (Pneumonitis) 01/2024 - 01/2014
2	Weight Loss (Weight Reduction) 01/2024 - 05/2014
2	Rheumatoid Arthritis 01/2022 - 11/2017
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2017
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2014
2	Cytokine Release Syndrome 05/2014 - 01/2014
1	Diabetes Mellitus 01/2024
1	Hyperglycemia 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Measles 01/2023
1	Acute Disease 01/2023
1	RNA Virus Infections 06/2022
1	Tularemia 01/2022
1	Convalescence 11/2021
1	Lymphoma (Lymphomas) 09/2021

Drug/Important Bio-Agent (IBA)

47	VaccinesIBA 05/2024 - 01/2009
29	EpitopesIBA 01/2024 - 06/2004
24	CytokinesIBA 03/2024 - 11/2002
23	AntigensIBA 01/2024 - 06/2004
19	Peptides (Polypeptides)IBA 01/2024 - 04/2005
14	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2002
13	AntibodiesIBA 05/2024 - 12/2014
11	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2024 - 01/2014
11	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 06/2006
9	ChemokinesIBA 03/2024 - 11/2002
9	HLA-A Antigens (HLA-A)IBA 11/2023 - 04/2016
8	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2014
8	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 02/2012 - 01/2006
6	Immunoglobulin G (IgG)IBA 01/2024 - 01/2021
6	Neutralizing AntibodiesIBA 11/2023 - 01/2015
6	Granzymes (Granzyme)IBA 01/2023 - 09/2008
5	NucleoproteinsIBA 01/2022 - 04/2005
5	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 07/2017
4	Interleukin-18 (Interleukin 18)IBA 10/2023 - 01/2016
4	HLA-A*24:02 antigenIBA 01/2022 - 04/2016
3	HLA-DR Antigens (HLA-DR)IBA 03/2024 - 01/2020
3	HLA-B Antigens (HLA-B)IBA 01/2024 - 04/2016
3	COVID-19 VaccinesIBA 11/2023 - 01/2023
3	Interleukin-10 (Interleukin 10)IBA 10/2023 - 11/2008
3	Interferon Type IIBA 06/2022 - 01/2014
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 05/2011
3	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022 - 12/2019
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 01/2020
3	Pattern Recognition ReceptorsIBA 01/2021 - 10/2019
3	InterferonsIBA 01/2021 - 01/2014
3	PerforinIBA 01/2020 - 09/2008
3	LipopeptidesIBA 05/2012 - 03/2006
2	Monoclonal AntibodiesIBA 03/2024 - 01/2019
2	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2021
2	BNT162 VaccineIBA 01/2024 - 01/2023
2	Interleukin-8 (Interleukin 8)IBA 11/2023 - 10/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 08/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 08/2021
2	Glycoproteins (Glycoprotein)IBA 10/2021 - 01/2006
2	LigandsIBA 02/2021 - 01/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 02/2003
2	Viral RNAIBA 01/2021 - 01/2014
2	Neuraminidase (Sialidase)IBA 11/2020 - 01/2015
2	Oseltamivir (Tamiflu)FDA Link 11/2020 - 01/2015
2	Interleukin-2 (IL2)IBA 01/2020 - 08/2007
2	GlycolipidsIBA 01/2020 - 11/2017
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2020 - 05/2011
2	Immunologic Factors (Immunomodulators)IBA 01/2015 - 02/2007
2	AcidsIBA 11/2006 - 04/2005
2	Amino Acids FDA Link 01/2006 - 04/2005
1	Messenger RNA (mRNA)IBA 03/2024
1	ocrelizumabIBA 03/2024
1	IonomycinIBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	Combined VaccinesIBA 01/2024
1	mRNA VaccinesIBA 11/2023
1	tixagevimabIBA 11/2023
1	cilgavimabIBA 11/2023
1	zanubrutinibIBA 02/2023
1	Tetanus ToxinIBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Nucleocapsid ProteinsIBA 01/2022
1	Subunit VaccinesIBA 10/2021

Therapy/Procedure

9	Therapeutics 02/2023 - 02/2003
8	Immunotherapy 10/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2004
2	Highly Active Antiretroviral Therapy (HAART) 05/2006 - 01/2005
1	Local Anesthesia 01/2022